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Atrial natriuretic peptide (ANP) binding sites have been detected in the embryonic brain, but the specific receptor subtypes and biological
functions for ANP family ligands therein remain undefined. We now characterize the patterns of gene expression for the natriuretic peptides
[ANP, brain natriuretic peptide (BNP), type-C natriuretic peptide (CNP)] and their receptors (NPR-A, NPR-B, NPR-C) at several early stages
in the embryonic mouse nervous system by in situ hybridization, and begin to define the potential developmental actions using cell culture
models of peripheral (PNS) and central nervous systems (CNS). In the CNS, gene transcripts for CNP were present at the onset of
neurogenesis, embryonic day 10.5 (E10.5), primarily in the dorsal part of the ventricular zone (VZ) throughout the hindbrain and spinal cord.
On E14.5, new CNP signals were observed in the ventrolateral spinal cord where motor neurons reside, and in bands of cells surrounding the
spinal cord and hindbrain, localized to dura and/or cartilage primordia. ANP and BNP gene transcripts were not detected in embryonic brain,
but were highly abundant in the heart. The CNP-specific receptor (NPR-B) gene was expressed in cells just outside the VZ, in regions where
post-mitotic neurons are differentiating. Gene expression for NPR-C, which recognizes all natriuretic peptides, was present in the roof plate
of the hindbrain and spinal cord and in bilateral stripes just dorsolateral to the floor plate at E12.5. In the PNS, NPR-B and NPR-C transcripts
were highly expressed in dorsal root sensory (DRG) and cranial ganglia beginning at E10.5, with NPR-C signal also prominent in adjoining
nerves, consistent with Schwann cell localization. In contrast, NPR-A gene expression was undetectable in neural tissues.
To define ontogenetic functions, we employed embryonic DRG and hindbrain cell cultures. The natriuretic peptides potently stimulated
DNA synthesis in neuron-depleted as well as neuron-containing Schwann cell cultures and differentially inhibited neurite outgrowth in DRG
sensory neuron cultures. CNP also exhibited modest survival-promoting effects for sensory neurons. In marked contrast to PNS effects, the
peptides inhibited proliferation of neural precursor cells of the E10.5 hindbrain. Moreover, CNP, alone and in combination with sonic
hedgehog (Shh), induced the expression of the Shh target gene gli-1 in hindbrain cultures, suggesting that natriuretic peptides may also
modify patterning events in the embryonic brain. These studies reveal widespread, but discrete patterns of natriuretic peptide and receptor
gene expression in the early embryonic nervous system, and suggest that the peptides play region- and stage-specific roles during the
development of the peripheral and central nervous systems.
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1 These authors made equal contribution to the present work.Natriuretic peptides constitute a family of three structur-
ally related hormones: atrial natriuretic peptide (ANP), brain
natriuretic peptide (BNP), and the type-C natriuretic peptide
(CNP) (Anand-Srivastava and Trachte, 1994; Espiner et al.,
1995; Nakao et al., 1992; Needleman et al., 1989). Natri-
uretic peptides were first discovered as hormones produced
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and water homeostasis, and other cardiovascular functions
through actions on the kidney and vascular smooth muscle
cells. There are three known mammalian receptors for
peptides in the ANP family (Anand-Srivastava and Trachte,
1994; Nakao et al., 1992). Two of these, types A and B
(NPR-A and NPR-B, respectively), are single transmem-
brane-spanning proteins that contain guanylyl cyclase (GC)
activity in their intracellular domain. In contrast, while the
type C receptor (NPR-C) also spans the plasma membrane
once, it contains only a short 37-amino-acid intracellular
domain that lacks GC activity. Because NPR-C is devoid of
GC activity and is internalized after peptide binding, it has
been referred to as the ‘‘clearance’’ receptor. However, more
recent data obtained using specific receptor agonists indicate
that NPR-C can indeed transmit intracellular signals, leading
to inhibition of cAMP formation, stimulation of intracellular
calcium levels, and/or reduction in the MAPK signaling
pathway (Prins et al., 1996; reviewed in Anand-Srivastava
and Trachte, 1994). Members of this receptor family differ
in their relative affinities for the natriuretic peptides. NPR-A
binds ANP and BNP with high affinity and CNP with very
low affinity. On the other hand, NPR-B is relatively selec-
tive for CNP, whereas NPR-C binds all natriuretic peptides
with relatively high affinity.
Recent data suggest that natriuretic peptides regulate the
development and function of several organ systems
(reviewed in Appel, 1992). For example, natriuretic peptides
regulate longitudinal growth of bones in explant assays, and
transgenic mice that overexpress BNP, or carry targeted
mutations in the NPR-C gene, exhibit pronounced skeletal
overgrowth (Matsukawa et al., 1999; Suda et al., 1998).
Natriuretic peptides may also play roles in the developing
brain: 125I-ANP binding sites were detected in embryonic
mouse and rat brains (Brown and Zuo, 1995; Scott and
Jennes, 1991; Tong and Pelletier, 1990; Zorad et al., 1993),
and CNP and ANP mRNA transcripts were detected in
embryonic brain and dorsal root ganglia (DRG), respective-
ly (Cameron et al., 1996). Finally, an NPR-C specific analog
was shown to inhibit DNA synthesis in mitogen-treated
cultures of rat glial cells from rat brain (Prins et al., 1996),
and Simpson et al. (2002) recently showed that CNP
inhibited proliferation and promoted survival of postnatal
mouse olfactory precursors.
We previously showed the neural crest-derived sympa-
thetic neuroblastoma cell line Neuro2 A expresses NPR-A
and NPR-B receptors, and that ANP and CNP stimulated
proliferation at low concentrations (Lelie`vre et al., 2001).
Higher concentrations inhibited proliferation by another
mechanism, which seemed to involve a NPR-C-like receptor.
These, and the above data, suggest that natriuretic peptides
perform growth factor-like functions in the developing brain.
To characterize ontogenetic expression of natriuretic pepti-
des and receptors in mice, and identify potential sites of
peptide action, we performed in situ hybridization on em-
bryonic mice using probes specific for each member of theligand and receptor families. Then, to explore potential
developmental functions, we employed embryonic DRG
and hindbrain cultures to define peptide effects. The natri-
uretic peptides regulated precursor cell proliferation, neuro-
nal survival, and process outgrowth in these culture models,
suggesting that natriuretic peptide function contributes to
region-specific nervous system development.Methods
In situ hybridization
ND4 mice were mated overnight and checked the follow-
ing morning for a vaginal plug. If a plug was present, the time
was designated as embryonic day E0.5.Mice at E10.5, E12.5,
and E14.5 were immersion fixed in 4% paraformaldehyde in
PBS overnight at 4jC. After cryoprotection in 30% sucrose in
PBS, embryos were frozen in OCT embedding compound
(Tissuetek, Miles Inc.). Transverse or sagittal sections (10–
16 Am) were mounted on slides (Superfrost Plus, Fisher Sci.),
then stored at20jC. Subsequent processing of slides and in
situ hybridization conditions were as described (Waschek et
al., 1998). The templates for receptor riboprobe synthesis
were generated using RT-PCR as previously described (Lelie`-
vre et al., 2001). The templates for the ligands were obtained
by RT-PCR using total RNA from mouse brain as template.
Primers (BRL/Life Technology) were designed using the on-
line Primer3 software based on mouse or rat sequences
published in NCBI database (GenBank). Sense and antisense
primers were 5V-CATCAGATCGTGCCCCGACCC-3V and
5V-AGGGGTGAGGATCTACTATAA-3V, respectively for
ANP, 5V-CCGATCCCTTCTGCA GCATGG-3V and 5V-
AAAGGTGGTCCCAGAGCTGGGG-3V for BNP, and 5V-
CAGCAGTAGGACCCGTGCTCGC - 3 V a n d 5 V-
CCTCCTTTGTATTTGCGCGC-3V for CNP. Amplifications
were carried out for 35 cycles of denaturation (94jC, 50 s),
annealing (54jC, 45 s), and extension (72jC, 45 s). PCR was
finished by an incubation for 5 min at 72jC. Amplified
sequences were cloned into PCRII-Topo (Clontech), se-
quenced to confirm identity, and then cloned into pBlue-
scriptII-SK (Stratagene). The sizes of the amplified cDNAs
were 765, 475, and 431 bp for ANP, BNP, and CNP,
respectively. Antisense riboprobes were made using NotI
and Sp6, XhoI and Sp6, BamHI and T7, BamHI and T7,
ApaI and T3, and PstI and T7 for ANP, BNP, CNP, NPR-A,
NPR-B, and NPR-C, respectively. Sense probes were made
with SacI and T7, SacI and T7, XhoI and Sp6,HindIII and T3,
HindIII and T7, and KpnI and T3 for ANP, BNP, CNP, NPR-
A, NPR-B, and NPR-C, respectively.
Dorsal root ganglion (DRG) cell cultures
For each experiment, DRG from four to five E14.5 rats
were dissected and incubated with 0.25% trypsin at 37jC for
20 min. After exposure to trypsin inhibitor (1 mg/ml) and
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mechanically dissociated and cells were plated (105 cells) on
poly-D-lysine (0.1 mg/ml)-coated 24-multi-well plates
(Nunc, Denmark). Culture medium was composed of a 1:1
(v/v) mixture of Ham’s F-12 and DMEM (Gibco, Grand
Island, NY) supplemented with transferrin (100 Ag/ml;
Calbiochem, La Jolla, CA), putrescine (100 AM), progester-
one (20 nM), selenium (30 nM), glutamine (2 mM), glucose
(6 mg/ml), bovine serum albumin (10 mg/ml), penicillin (50
U/ml), and streptomycin (50 Ag/ml) as previously reported
(Lu and DiCicco-Bloom, 1997), with products from Sigma
unless otherwise indicated. The natriuretic peptides (Penin-
sula) were diluted from 104 M stocks (dissolved in water)
and added directly in culture media. Dose response analyses
of peptide effects on DNA synthesis and survival were
performed in the absence of added neuronal trophic factors.
Under these conditions, approximately 10–15% of cells
observed at 24 h incubation were neurons by morphological
and immunocytochemical characteristics, yielding a glial-
enriched culture. However, in other experiments, active
peptide doses were assessed for mitotic activity in cultures
containing 3 ng/ml of NGF, conditions promoting sensory
neuron survival and neuron–glial interactions and modeling
normal ganglion tissue composition.
In contrast, to assess effects of natriuretic peptides on
neuronal processes, cells were incubated with the addition
of insulin (10 Ag/ml) and NGF (3 ng/ml) to enhance neuron
survival (see Results).
DNA synthesis in DRG cultures
Incorporation of [3H]thymidine ([3H]dT) into cellular
precipitates was used to assay DNA synthesis in DRG
cultures. Cells were treated with various doses of ANP,
CNP, and des-[Gln(18),Ser(19),Gly(20),Leu(21),Gly(22)]-
ANP(4-23)-NH(2) (desANP4-23) for 24 h on poly-D-lysine-
coated 24-multi-well plates, in the absence and presence of
NGF (3 ng/ml). [3H]dT was added for the final 4 h of
incubation, and incorporation was analyzed by scintillation
spectroscopy, as previously described (Lu and DiCicco-
Bloom, 1997). To quantify and characterize mitotically
responsive cells, we assessed nuclear incorporation of thy-
midine analog, bromodeoxyuridine (BrdU), using double
immunocytochemistry. Dissociated DRG cells plated on
poly-D-lysine-coated 35-mm dishes at a cell density of 3 
105 cells/dish were incubated with various concentrations of
natriuretic peptides and BrdU (10 AM) using several para-
digms. To assess peptide mitotic effects, cells were incubat-
ed in control and CNP-containing medium for 1, 2, and 3
days (peptides were refreshed at 48 h), and cultures were
fixed after a 4-h terminal BrdU pulse. Following immuno-
cytochemical staining (see below), the mitotic labeling index
(LI) was determined as the ratio of BrdU-positive cells to
total cells visualized under phase microscopy, assessing 2–
3% of the dish surface area as reported (Carey et al., 2002;
DiCicco-Bloom et al., 2000; Lu and DiCicco-Bloom, 1997).Immunocytochemistry
To characterize mitotic cells in DRG cultures, dissociated
cells (3  105 cells) were incubated continuously with BrdU
in 35-mm dishes for 24 and 72 h, fixed with 4% paraformal-
dehyde, and stained with antibodies to BrdU (1:50; Beckton
Dickinson); Schwann cell markers, S100 (1:200; Sigma) and
p75 (1:100; Sigma); astrocyte marker, glial fibrillary acidic
protein (GFAP, 1:1000; Sigma), and neuronal marker, hIII
tubulin (TuJ1, 1:500; clone TU-20, Biogenesis, Poole, UK).
To identify BrdU-positive cells for assessment of the labeling
index (LI), nuclear immunoreactivity was detected using the
VectorStain ABC kit, as previously reported (Carey et al.,
2002; DiCicco-Bloom et al., 2000; Lu and DiCicco-Bloom,
1997). BrdU-expressing cells bearing Schwann cell markers
were assessed using double immunofluorescent markers. The
rabbit glial marker polyclonal antibodies were detected using
goat anti-rabbit antibodies conjugated to Alexafluor 488
(1:200, green). Following 4% paraformaldehyde fixation,
BrdU labeling was performed as above, detected using goat
anti-mouse Alexafluor 594 (1:200, red). The Alexafluor
products were from Molecular Probes, Inc (Eugene, OR).
Double labeling was assessed using a Leica DM IRB
inverted fluorescent microscope equipped with a dual red/
green filter system. To capture cells for presentation, an
Optronics Digital camera imported images to a PC computer,
fluorescent signal was recorded in black and white and
subsequently pseudo-colored as red or green and overlaid,
using Adobe Photoshop software, as previously reported
(Nicot and DiCicco-Bloom, 2001).
Neuronal survival and neurite outgrowth
To characterize peptide effects on neuronal survival,
dissociated DRG cells (3  105 cells) were incubated in
35-mm dishes for 24 h in defined medium (see Dorsal root
ganglion (DRG) cell cultures section above) without added
trophic factors. Under these conditions, approximately 10–
15% of cells in control medium were neurons by morpho-
logical and immunocytochemical characteristics. Three cul-
ture dishes were examined for each group under phase
microscopy in two separate experiments, yielding N = 6.
The number of neurons, identified as round cells bearing
uniform processes >2 cell diameters in length and staining
with TuJ1, was counted in two to three randomly selected,
nonoverlapping 1-cm strips (3% of the culture dish area) as
previously described (DiCicco-Bloom et al., 1993, 2000).
To characterize natriuretic peptide effects on neuronal
process outgrowth, DRG cells were cultured in the presence
of 10 Ag/ml insulin and 3 ng/ml of NGF to enhance cell
survival. To optimize the measurement of neurite length
without cellular overlap, we plated 5  104 cells per 35-mm
dish. Cells were fixed at 24 h incubation and stained with
TuJ1 antibody to enhance detection of long neurites and
growth cones. Data were obtained from three separate
experiments, each consisting of two to three dishes per
tal Biology 271 (2004) 161–175 163
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fication were randomly photographed and the length in
micrometers of the longest neurite was measured for each
cell using NIH Image (object-image) software. After com-
bining measurements from all fields from the three experi-
ments, the total number of cells assessed for each group
was: Control, 349; ANP, 221; CNP, 151; and dANP, 264.
DNA synthesis in E10.5 hindbrain neural tube progenitors
E10.5 mouse hindbrain cells were isolated as described
(Waschek et al., 1998), plated at 60,000 cells/well in 96-well
tissue culture plates in Neurobasalk medium supplemented
with 1%FBS and 1 ng/ml FGF-2 (Invitrogen/GibcoBRL),
and treated on the following day for 24 h with natriuretic
peptides at concentrations from 1012 to 106 M as previ-
ously described (Lelie`vre et al., 2002). [3H]thymidine was
added along with fresh drug for the last 6 h of treatment,
after which cells were extracted in 0.5 M NaOH. Incorpo-
rated [3H]thymidine was precipitated by TCA and assayed
as previously described (Lelie`vre et al., 1998).
Analysis of gli-1 gene expression in E10.5 hindbrain neural
tube progenitors by real-time PCR
Cells were isolated from E10.5 mouse hindbrain as
described above and treated for 8 h with 10 nM CNP
(Peninsula), 700 ng/ml Shh (R&D Systems), or the combi-
nation of CNP and Shh. Total RNA was isolated, reverse
transcribed, and analyzed for gli-1 and h2-microglobin
mRNA by real-time PCR. To obtain primers, cDNA encod-
ing Gli-1 was first analyzed for secondary structures using
M-fold software (BioRad). Portions of sequence lacking
secondary structure were imported into Oligo6 software
(Molecular Biology Insights) to design highly stringent
primer sets. For Gli1, we chose the following oligonucleo-
tides 5V-ATCTCTCTTTCCTCCTCCTCC-OH and 5V-
CGAGCCTGGCATCAGAA, as sense and antisense pri-Fig. 1. NPR-B receptor gene expression in E10.5 mouse embryos, detected by in si
field views, respectively, of a coronal section of the hindbrain (dorsal/ventral orie
grains, which are black in bright field but white in dark field. NPR-B transcripts a
neurons undergo differentiation (arrows). Intense signal is present in the cranial tr
cord that shows NPR-B expression in bilateral segmental DRG. 4V = fourth venmers, respectively. PCR amplification resulted in the gen-
eration of a single band at 95 bp, corresponding to the
regions 356–449 of the previously published sequence of
mouse Gli-1 mRNA (NM010296). To standardize the
experiments, we designed, using the same approach, a
primer set (5-CCGGCTTGTATGCTATC and 5-AGTT-
CATGTTCGGCTTC, as sense and antisense, respectively),
for the mouse h2-microglobulin gene. These primers am-
plified an 87-bp region encoding the nucleotides 99–185 of
the published sequence (MM2BMR) of the mouse mRNA.
Amplified gli-1 and h2-microglobulin bands were cloned
into PCRII and sequenced to confirm identity. Real-time
PCR was set up using sybergreen-containing supermix from
Biorad, for 50 cycles of a three-step procedure including a
30-s denaturation at 96 jC, a 30-s annealing at 60 jC,
followed by a 30-s extension at 72jC. Amplification spec-
ificity was assessed by melting curve. Quantification uti-
lized standard curves made from serial dilutions of control
RNA sample or of the corresponding cDNA cloned into
PCRII vector. Differences between samples were calculated
as the difference between the specific ratios (gli-1/h2-micro-
globulin) calculated for each individual sample.Results
Localization of natriuretic peptide and receptor gene
expression
NPR-A and NPR-B receptor gene expression
NPR-A gene expression was not detected within the
brain or any ganglia at E10.5 or E12.5, although transcripts
were observed in many blood vessels (data not shown). In
contrast, intense NPR-B expression was primarily localized
to the nervous system from E10.5 to E12.5, and was not
detectable in vascular tissue. The NPR-B gene was
expressed in the brain at E10.5 in cells just outside the
ventricular zone (VZ) of the hindbrain, a region where post-tu hybridization using a 33P-labeled riboprobe. A and B are bright-and dark-
ntation is indicated). Dark-field photos are shown to better visualize silver
ppear to be localized to a region just outside of the VZ, where post-mitotic
igeminal ganglion. C is a dark-field view of a section parallel to the spinal
tricle; 5g = trigeminal ganglia; DRG = dorsal root ganglia.
Fig. 2. NPR-B (A, B) and CNP (C, D) gene expression in the area of the spinal cord in E14.5 mice. A and C are bright-field micrographs; B and D are the same
sections shown in dark field. DRG are indicated by asterisks (*) in all panels, and are strongly labeled by the NPR-B riboprobe in A and B. A population of
CNP-mRNA-hybridizing motor neurons is indicated by large arrows in C and D. Arrowheads in D point to a band of CNP mRNA-positive cells that surrounds
the spinal cord and DRG and may correspond to dura and/or chondrocytes in the growth plate of primordial bone (see text). Small arrow in D points to an area
of intense CNP gene expression in the dorsal VZ (DVZ) of the spinal cord.
Fig. 3. NPR-C receptor gene expression in E10.5 mouse embryos. All sections are coronal, with dorsal/ventral and anterior/posterior orientations indicated.
Images are bright-field photos at different levels of the embryo, except for panel D, which is a dark-field view of C. Sections at the level of the pons (A),
diencephalon (B), and spinal cord (C, D) demonstrate NPR-C transcript expression in perivascular plexuses and major blood vessels. Intense signal is present in
or near the forebrain lamina terminalis or emerging choroid plexus (E) and the pontine trigeminal ganglion (F). 4V = fourth ventricle; PNVP = perineural
vascular plexus; CA = carotid artery; R = opening to Rathke’s pouch; NC = notochord; DA = dorsal aorta; FG = pharyngeal region of the foregut; TV =
telencephalic vesicle; 5g = trigeminal ganglia.
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Very high NPR-B expression was observed in several
developing ganglia at E10.5, including the cranial trigeminal
ganglion (Figs. 1A, B) and the segmental dorsal root ganglia
(DRG) (Fig. 1C). This intense gene expression in sensory
ganglia was maintained until at least E14.5 (Figs. 2A, B).
NPR-C receptor gene expression
The NPR-C gene was highly expressed at E10.5 in the
area surrounding the neural tube (Fig. 3A), presumably the
perineural vascular plexus, in the major arteries (Figs. 3B–
D) and to a lesser extent in the veins (not shown). Expres-
sion was also observed in the notochord (Figs. 3C, D), a
structure well known to produce diffusable factors, such as
sonic hedgehog, responsible for dorsal/ventral pattering of
neurons and glia in the neural tube. NPR-C expression was
also observed in the heart and surface ectoderm (not shown).
In the E10.5 nervous system, NPR-C expression was
detected in (or near) the lamina terminalis or emerging
choroid plexus (Fig. 3E), and in several cranial ganglia,
such as the trigeminal (Fig. 3F). At E12.5, NPR-C gene
expression continued to be observed in the perineural
vascular plexus and surface ectoderm (Figs. 4A, B), the
segmental DRG (Figs. 4C, D), and the trigeminal ganglia
(Figs. 4E, F). Analysis of sagittal sections surrounding the
trigeminal ganglia also revealed intense signal in the oph-
thalmic, maxillary, and mandibular nerves, very likely
reflecting Schwann cell expression (Figs. 4E, F). New sitesFig. 4. NPR-C receptor gene expression in E12.5 mouse embryos. Panels A and B
and F are dark-field views of A, C, and E, respectively. NPR-C transcripts are inten
trigeminal nerve branches, including the mandibular and maxillary (E, F). Dorsal
telencephalic vesicle; PNVP = perineural vascular plexus; DRG = dorsal root gang
5man = mandibular nerve.of CNS gene expression at E12.5 included the roof plate and
two bilateral stripes that surrounded the floor plate (Figs.
5A, B), and the choroid plexus (not shown). The bilateral
stripes of signal surrounding the floor plate may represent
NPR-C gene expression in glial precursors (Pringle and
Richardson, 1993), or one of the NKX or other homeobox
gene expression domains that give rise to specific subclasses
of ventral neurons (Tanabe and Jessell, 1996). Small discrete
clusters of NPR-C gene transcripts were observed within the
forebrain neuroepithelium, presumably over invading cap-
illaries, whereas broad expression was seen in overlying
surface ectoderm (Figs. 5C, D). At E14.5, NPR-C gene
expression was still high in the DRG, but transcripts in the
spinal cord roof plate and surrounding the floor plate could
no longer de detected (data not shown).
Natriuretic peptide gene expression
Sagittal sections at E12.5 revealed CNP peptide gene
transcripts at all levels of the CNS caudal to the mesen-
cephalon (Figs. 6A, B), with more restricted dorsal locali-
zation in the spinal cord. A very similar pattern of
expression was observed at E10.5 (data not shown). Trans-
verse sections of spinal cord revealed that CNP transcripts
were localized in the dorsal and intermediate ventricular
zone (VZ) and possibly in more lateral regions (Figs. 6C,
D). Later, at E14.5, CNP expression was still observed at
high levels in the VZ, although new signal was seen
laterally in cells in the dorsal hindbrain, reflecting eitherare coronal sections; C and D are in a plane parallel to the spinal cord. B, D,
sely expressed in the vascular plexus (A, B), in segmental DRG (C, D), and
/ventral (D/V) and anterior/posterior (A/P) orientations are indicated. TV =
lia; 5n = trigeminal nerve; 5g = trigeminal ganglia; 5max = maxillary nerve;
Fig. 5. NPR-C receptor gene expression in the spinal cord and telencephalon in E12.5 mouse embryos. All panels are transverse sections. New gene expression
is localized to the roof plate and in stripes surrounding the floor plate (A, B). B is a magnification of the area within the rectangle in A. Signal is also present in
invading forebrain capillaries, and in overlying surface ectoderm (C, D). D is a dark-field view of C. RP = roof plate; FP = floor plate; LV = lateral ventricle.
Arrows in C and D point to one of several capillaries (Ca) shown in this section of the telencephalon.
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F). Specific hybridization signals were also observed in cells
surrounding the neural tube, apparently the dural layer of the
meninges. In the area of the spinal cord, CNP mRNA was
again detected in the dorsal VZ, but now also in the
ventrolateral cord, where motor neurons are localized (Figs.
2C, D). CNP mRNA was also detected in a band of cells
surrounding the spinal cord, possibly the dura as observed in
the hindbrain (Fig. 6F), and adjacent to the DRG which
express both NPR-B and NPR-C receptor mRNAs (see
above). Alternatively, this cellular band may represent the
perichondrial lining of the spinal canal, which at this stage,
participates in appositional growth of the vertebral column.
In this regard, CNP is known to be expressed in chondo-
cytes in the growth plate of developing skeletal bones
(Chusho et al., 2001). In contrast to CNP, ANP and BNP
gene transcripts were not detected in the nervous system, but
were expressed at high levels in the heart (data not shown).
Action of natriuretic peptides on neural cells in culture
Effects of natriuretic peptides on DNA synthesis in DRG cell
cultures
The foregoing expression studies indicated that both
NPR-B and NPR-C receptor transcripts are present in cranial
and dorsal root sensory ganglia, raising the possibility that
the natriuretic peptides elicit ontogenetic effects. To begindefining activities, E14.5 rat DRG were dissociated and
plated in fully defined medium containing various peptide
concentrations, and assessed for effects on DNA synthesis.
Cells were incubated in the absence of the mitogen/survival
factor, insulin, and the neurotrophin, nerve growth factor
(NGF), to enhance our detection of possible stimulatory
activity which may be masked by other mitogens. Signifi-
cantly, insulin family members are potent mitogens for
peripheral ganglion cells, whereas axons of NGF-dependent
sensory neurons possess well-characterized Schwann cell
mitogenic activity (Ratner et al., 1985; Recio-Pinto et al.,
1986). Incorporation of [3H]thymidine during a terminal 4
h of a 24-h incubation was assessed. CNP elicited a 2-fold
increase in DNA synthesis, with an EC50 of 10
9 M and peak
activity at 108 M (Fig. 7A), indicating that DRG cells
possess functional receptors. Significantly, desANP4-23, a
ligand relatively selective for NPR-C receptors, exhibited far
greater potency, with an EC50 of approximately 10
10 M and
a peak effect at 109 M (Fig. 7B). In contrast, while ANP
also increased DNA synthesis, effects were not observed
until a dose of 107 M (revealed by ANOVA; Fig. 7C) with
an EC50 of approximately 10
8 M (compared to Control
using Student’s t test). The high potency of both CNP and
desANP4-23 in the mitogenic stimulation of DRG cells
suggests actions at both NPR-B and NPR-C receptors,
consistent with their expression in the embryonic DRG
(Figs. 1C, 2A, B, 4C).
Fig. 6. CNP gene expression in E12.5 (A–D) and E14.5 (E–F) mouse embryos. CNP gene transcripts at E12.5 are present from the mesencephalon to the
caudal spinal cord (A–D). CNP mRNA is particularly abundant in the dorsal region, including the VZ, especially in the caudal portions of the spinal cord (C,
D). At E14.5 (E, F), CNP expression is maintained in the VZ and is present in scattered cells of the dorsolateral tegmentum. B, D, and E are bright-field views
of A, C, and E, respectively. A and B are sagittal sections. C–F are coronal sections. M = medulla; SC = spinal cord; 4v = fourth ventricle; 3v = third ventricle.
Du = cells associated with the dura. Arrows in C point to abundant hybridizing transcripts in the VZ of the dorsal part of the spinal cord.
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next determined whether 107 M CNP, the most effective
peptide and concentration in the above cultures, elicited
mitogenic effects in the presence of neurons, a condition
more relevant to neuron–glial interactions occurring in
vivo. Neuron survival was maintained by adding the neuro-
trophin, NGF, at 3 ng/ml. CNP stimulated DNA synthesis
by approximatelyf40% in DRG cultures maintained in the
presence of NGF (Con = 5896 F 680; CNP = 8274 F 96;
mean cpm F SEM; P < 0.02; N = 7). Furthermore, when
neuron survival promotion was diminished by reducing
NGF levels 3-fold, less neurons were present (data not
shown) and CNP elicited a 2-fold increase in DNA synthesis
(Con = 2510 F 30; CNP = 5134 F 65; P < 0.001),
consistent with previous reports that neurons provide a
mitogenic stimulus for Schwann cells in vitro (Ratner et
al., 1985). In previous work, we have found that the
presence of one mitogen can mask effects of another,
apparently due to limited numbers of precursors available
to enter the cell cycle (DiCicco-Bloom et al., 1993, 2000).
Regardless, in the presence of neuron–glial interactions that
occur in vivo, CNP may serve a mitogenic function.
Characterization of mitotic cells in DRG cultures
To characterize cells responsive to the natriuretic pep-
tides, we used immunocytochemistry to detect glial andneuronal markers, as well as nuclear BrdU mitotic labeling,
in two incubation paradigms. Cells were incubated in the
presence of NGF in control or CNP-containing medium for
1–3 days, and fixed after a 4-h BrdU pulse to define the
mitotic labeling index (LI). Alternatively, cells were incu-
bated for 3 days in the continuous presence of BrdU to
characterize the neural traits expressed by cells undergoing
DNA synthesis. In preliminary studies performed without
NGF addition, a condition yielding few neurons (approxi-
mately 10%) based on morphology and TuJ1 expression, we
observed bipolar cells at 24 h expressing glial markers,
including the low-affinity NGF receptor, p75, as well as
S100, as reported previously (Jessen and Mirsky, 1991;
Lemke and Chao, 1988; Mata et al., 1990; Taniuchi et al.,
1988). When incubated for 3 days, many GFAP-positive
cells were found (data not shown), consistent with Schwann
cell maturation in the absence of neurons (Jessen and
Mirsky, 1984).
To characterize mitogenic effects, DRG cells were incu-
bated in NGF-containing medium, in the absence (Control)
or presence of CNP (107 M) and the LI was determined.
CNP elicited a 2-fold increase in mitotic cells at 24 h,
increasing the LI from 10% in control to 21% in the presence
of the peptide (Fig. 8). The labeling index increase elicited by
CNP was consistent with the peptide’s effects on [3H]thymi-
dine incorporation (Fig. 7). Furthermore, there was a pro-
Fig. 7. Effects of natriuretic peptides on [3H]thymidine incorporation in
E14.5 rat DRG cell cultures. Dissociated DRG cells were plated in fully
defined medium in the absence of insulin and NGF. Cells were incubated
for 24 h in control medium or medium containing various peptide
concentrations and incorporation of [3H]thymidine during a 4-h terminal
pulse was assessed. Data represent incorporation into six to eight culture
wells per group from two to three separate experiments and are expressed as
cpm F SEM. *P < 0.05. dANP = des ANP4-23.
Fig. 8. Effects of CNP on the mitotic labeling index (LI) in E14.5 rat DRG
cell cultures. Cells were incubated in medium containing NGF (3 ng/ml) in
the absence (Control) or presence of CNP (107 M) for 1–3 days and fixed
after a terminal 4-h pulse with BrdU and assessed by immunocytochem-
istry. Data are expressed as the percentage F SEM of cells exhibiting BrdU
nuclear labeling. It should be noted that BrdU labeling was not observed in
cells exhibiting a neuronal morphology or TuJ1 expression, consistent with
previous evidence that neurogenesis is complete in rat DRG by E13
(Lawson et al., 1974).
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the LI was 19% in control and 33% in CNP-treated cultures
(Fig. 8), suggesting sustained peptide mitogenic activity.
To identify cells undergoing mitosis, we double labeled
cells exposed continuously to BrdU for 3 days for several
glial markers, including p75, S100 and GFAP. The majority
of mitotic cells at 3 days, identified by nuclear BrdU
labeling, also expressed glial marker GFAP (90 F 4.0%).
As shown at low magnification (Figs. 9A–C), many of the
cells identified by phase microscopy at 3 days (Fig. 9A)
exhibit BrdU (+) nuclei (Fig. 9B) which co-label with
cellular GFAP signal (Fig. 9C). At higher magnification
(Figs. 9D–F), BrdU-positive nuclei frequently associate
with GFAP signal, which, on close inspection, appear as
extended cytoplasmic filaments in these elongated cells.
Extended BrdU-labeled cells also co-label with glial marker
S100 which appears in either cytoplasmic or nuclear com-
partments (Figs. 9G–L). Double labeling analysis indicated
that the majority of cells incorporating BrdU during 3 days of
incubation expressed the Schwann cell markers, p75 (77 F
4.9%) and S100 (67F 2.8%) along with the GFAP described
above. These observations suggest that CNP exhibits mito-
genic activity in mixed DRG cell cultures, stimulating
proliferation of Schwann cells over several days. In contrast,
no neuronal cell nuclei labeled with BrdU in these studies,
consistent with previous evidence that neurogenesis in rat
DRG is complete by E13 (Lawson et al., 1974).
Natriuretic peptide effects on DRG neuron survival
To examine potential trophic activity, we assessed the
effects of natriuretic peptides on survival of neuronal cells,
Fig. 9. Immunocytochemical characterization of mitotic cells in DRG cultures. DRG cells were incubated for 3 days in medium containing NGF (3 ng/ml),
CNP (10 7 M), and BrdU (10 AM), and then fixed and processed for glial markers (GFAP, S100; green) and BrdU (red) double immunocytochemistry. (A–C)
At low magnification, numerous cells observed under phase microscopy (A) exhibit nuclear BrdU labeling (B) that also co-localizes with GFAP (C). At higher
magnification, BrdU-positive nuclei (D) occur in extended cells with GFAP-positive cytoplasmic filaments (E), with co-localization shown in F. (G) A series of
flat, extended cells observed under phase (G) exhibit nuclear BrdU (H) that co-localizes with Schwann cell marker, S100 (I), which is found in both
cytoplasmic and nuclear compartments. (J–L) Another series of cells exhibit typical bipolar and extended morphologies of Schwann cells that double label for
BrdU and S100, similar to that seen for GFAP (A–C). Scale bar = 100 Am in A–C, and 50 Am in D–L.
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in the absence of the known trophic factors, insulin and
NGF. CNP had modest effects on neuron survival at 24 h,
increasing neuron number by only 50%, whether expressed
in absolute terms (Control = 23 F 2.7, CNP = 37 F 3.7,
mean cell number/3% dish area F SEM; N = 6; P < 0.0042)
or as a percentage of total cells in the dish (Control = 11 F
1.1%, CNP = 16 F 1.0%, mean percentage F SEM; N = 6;
P < 0.0015). This effect is relatively small compared to the
robust changes elicited by insulin and NGF, conditions in
which neurons comprised 51 F 3.3% of the cells in the dish
(mean percentage F SEM; two experiments, N = 8),
consistent with previously reported neurotrophic activities
(Recio-Pinto et al., 1986).
Natriuretic peptide effects on process outgrowth of DRG
sensory neurons
The foregoing mRNA expression studies suggest that
DRG neurons express NPR-B (Figs. 1C, 2A, B), while the
receptor’s preferred ligand, CNP, is present in regions where
sensory neuron terminals make targeting decisions, includingthe dura/developing vertebral column, the VZ of the dorsal
spinal cord, and the ventrolateral spinal cord motoneuron
pool (Figs. 2C, D). We thus hypothesized that CNP acts as an
axon guidance signal, eliciting terminal extension, repulsion
or attraction. In this respect, there is strong evidence that
cGMP, the primary second messenger for NPR-B, is an
important mediator or modulator of the effects of guidance
molecules such as netrin and semaphorins (Nishiyama et al.,
2003; Song et al., 1998). To examine the effects of natriuretic
peptides on DRG neuron process elaboration, we cultured
cells in the presence of insulin and NGF, which markedly
enhanced neuron survival, and employed low-cell culture
density (5  104 per 35-mm dish) to allow single cell
analysis. The addition of the natriuretic peptides in the
presence of NGF had no effects on neuronal survival (data
not shown). To define effects on neurite outgrowth, we
measured the lengths of the longest process, visualized by
TuJ1 staining, on each neuron. The overall effects of natri-
uretic peptides on process growth in the culture population
are depicted in Fig. 10A, whereas statistical significance was
determined using the population means (Fig. 10B).
Fig. 10. Effects of the natriuretic peptides on the length of sensory neuron
processes. (A) The overall effects of the peptides on process growth in the
population are shown. Low-density DRG cultures containing trophic
factors, insulin (10 Ag/ml) and NGF (10 ng/ml), were incubated in control
medium or medium containing natriuretic peptides (107 M), and fixed at 24
h for TuJ1 immunocytochemistry and process length assessment. Data were
obtained from three separate experiments, each consisting of two to three
dishes per group (N = 6–8 dishes), and 150–350 neurons in total for each
condition were assessed. Cell fields at 20 magnification were randomly
photographed and length (Am) of the longest neurite was measured using
NIH Image (object-image) software. Data are expressed as the percentage of
the cell population with a neurite equal to or greater than a given length.
Both ANP and CNP reduced neuronal process length, appearing to shift the
curves to the left. The curves for these peptides are almost superimposed.
The apparent right shift induced by dANP = des ANP4-23 (dANP) was not
statistically significant (see B). (B) The mean length of the longest neurite
was reduced by approximately 30% in the presence of 107M ANP or CNP.
*P < 0.001. ANOVA followed by Scheffe F test. Fig. 11. Inhibition of neuroblast proliferation by natriuretic peptides. Cells
were isolated from the hindbrain portions of the E10.5 mouse neural tubes
and cultured in Neurobasalk medium containing 1% FBS, 1 N2
supplement, and 1 ng/ml FGF-2, and treated on the following day for
24 h with natriuretic peptides at concentrations from 1012 to 106 M.
[3H]thymidine was added along with fresh drug for the last 6 h of treatment.
Mean [3H]thymidine incorporation values (FSEM, n = 3 determinations) at
various concentration of added peptides are shown. Values were fit using
Graphpad Prismk (ISI software). Data shown are representative of three
independent experiments. Statistical analyses using analysis of variance
(ANOVA) followed by Newman–Keul’s test revealed significant differ-
ences between controls and treatments at ***P < 0.001 or **P < 0.05.
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(Fig. 10A), though changes were not statistically significant
(Fig. 10B). In contrast, both ANP and CNP appeared to
induce a general shift to shorter processes on the cells (Fig.
10A), yielding a significant reduction in mean process length
in the population (Fig. 10B). Thus, in the presence of either
ANP or CNP, only approximately 30% of cells had processes
greater than 100 Am, whereas 50% extended this distance incontrol or desANP4-23-treated cultures. Conversely, twice as
many cells had processes of z200 Am in controls as in the
presence of ANP or CNP, whereas few cells extended to 300
Am when exposed to the peptides. Overall, ANP and CNP
reduced mean neurite length by 25–30% (Fig. 10B). The
neurite inhibitory effects of both ANP and CNP, without
effect of the NPR-C selective agonist, desANP4-23, suggest
that the peptides elicited effects via NPR-B receptor, which is
highly expressed in the DRG at this age (Figs. 2A, B).
Natriuretic peptide effects on DNA synthesis in E10.5 mouse
hindbrain neuroblast cultures
Our expression studies indicate that CNP is expressed in
the dorsal VZ of the hindbrain and spinal cord (Figs. 2C, D,
6A–F), whereas NPR-B gene is expressed transiently at
E10.5 in cells just outside the proliferative zone (Fig. 1).
This complementary localization pattern raises the possibil-
ity that VZ-derived peptide plays a role in controlling
precursor proliferation and/or differentiation. To determine
the effect of natriuretic peptides on neuroblast proliferation,
we measured [3H]thymidine incorporation in dispersed cell
cultures from this region in E10.5 embryos using methods
we reported previously (Lelie`vre et al., 2002; Waschek et
al., 1998). These proliferating cultures consist predominant-
ly of neural progenitors over the culture period, with
approximately 1–5% of cells staining for TuJ1 (h-tubulin),
and no cells staining for glial markers (A2B5, CNPase,
GFAP, GalC, NG2) or vimentin (data not shown). CNP
potently inhibited DNA synthesis in these cultures, with an
EC50 of approximately 0.1 nM (Fig. 11). ANP was clearly
less potent than CNP, whereas desANP4-23 exhibited activity
between CNP and ANP. The potent inhibitory action of
Fig. 12. Shh and CNP regulation of gli-1 gene expression in E10.5
hindbrain cultures. Cells were isolated from E10.5 mouse neural tubes and
cultured as described in the previous figure and were treated for 8 h with 10
nM CNP, 700 ng/ml Shh, or the combination of CNP and Shh. Total RNA
was isolated, reverse transcribed, and analyzed for gli-1 and h2-microglobin
(b2MG) mRNA by real-time PCR. Samples were measured in triplicate, and
the experiment was repeated twice. Statistical analysis (ANOVA) revealed
treatment effects are significantly different than control at P < 0.05.
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consistent with in situ hybridization studies showing the
presence of NPR-B gene expression in this embryonic brain
region. The fact that the NPR-C-specific analog desANP4-23
also inhibited DNA synthesis indicates that at least some of
the antiproliferative actions may be mediated through a
NPR-C- or NPR-C-like receptor. Although we could not
localize NPR-C mRNA in the embryonic hindbrain by in
situ hybridization, we previously detected its expression in
this region by RT-PCR (Lelie`vre et al., 2001). The data are
consistent with the possibility that CNP acts as an antimi-
totic agent and/or promotes the differentiation of E10.5
hindbrain precursors.
Another potential activity of CNP at early stages of
neural development would be to regulate the differentiation
of cells by modulating the activity of patterning factors such
as sonic hedgehog (Shh). There is precedence for factor
interactions in that ‘‘chick’’ natriuretic peptide was able to
enhance the ability of sonic hedgehog (Shh) to induce
ventral phenotypes in chick dorsal neural plate explants
(Robertson et al., 2001). We thus determined if Shh and
CNP interact in mouse embryonic hindbrain cultures by
analyzing the expression of the Shh target gene, gli-1. We
found that both CNP and Shh increased the expression of
gli-1, and that the combined effect was additive (Fig. 12).
Thus, CNP may modify proliferation and patterning events
in the E10.5 mouse hindbrain, acting across adjacent devel-
opmental compartments.Discussion
Our observations indicate that the natriuretic peptides
and their receptor subtypes exhibit region-specific expres-
sion patterns in the embryonic central and peripheral ner-vous systems, suggesting that the peptide systems play roles
in regulating neural development. Based on these expression
patterns, we employed both peripheral (PNS) and central
nervous system (CNS) cell culture models to study effects
on precursor cell mitosis, survival, neurite outgrowth, and
gene expression. The peptides elicited both stimulatory and
inhibitory mitogenic effects in both neuronal and glial
precursors, as well as altered neuronal survival and process
elaboration. The actions were natriuretic peptide subtype-
selective and region-specific.
Our localization studies provide detailed information on
the location as well as subtypes of natriuretic peptide
receptors expressed in the early embryo. In general, NPR-
B and NPR-C receptor gene expression patterns in the
hindbrain, spinal cord, and peripheral ganglia were consis-
tent with earlier reports of ligand binding during develop-
ment. Four different groups previously characterized ANP
binding sites using autoradiography, demonstrating high-
affinity natriuretic peptide binding sites in the developing
rat brain and associated blood vessels (Brown and Zuo, 1995;
Scott and Jennes, 1991; Tong and Pelletier, 1990; Zorad et
al., 1993). In the most comprehensive report, Scott and
Jennes (1991) observed that 125I-ANP binding sites at E14
were localized to the developing blood vessels and the
vascular plexus around the developing brain and in the
meningeal layer. In the spinal cord, bilateral accumulations
of silver grains were observed adjacent to (or over) the floor
plate and in the roof plate. Radioligand binding sites were
also observed over the dorsal roots, the DRG and peripheral
nerves, leading investigators to conclude that receptors were
localized to Schwann and satellite cells, and possibly sensory
neurons. 125I-ANP binds primarily to NPR-A and NPR-C
with high affinity, and thus may not detect NPR-B in receptor
autoradiographic studies. Because we detected intense NPR-
C gene expression (and not NPR-A mRNA) in all these sites,
it seems likely that the 125I-ANP binding sites reported in that
study corresponded to NPR-C. However, the current in situ
hybridization studies also demonstrated NPR-B transcripts
within the developing brain in addition to peripheral ganglia.
The natriuretic peptides elicited diverse ontogenetic
effects in PNS and CNS cultures, including bidirectional
control of proliferation, survival promotion, and inhibition
of neurotrophin-induced neurite outgrowth. In E14.5
DRG cultures, both CNP and NPR-C selective ligand,
desANP4-23, stimulated Schwann cell mitosis, identified
by double immunocytochemistry, consistent with the
expression of NPR-C receptors in developing ganglia
and peripheral nerves. The intense CNP gene expression
surrounding the spinal cord and DRG, apparently local-
ized to the dura and/or vertebral perichondrium, suggests
that the encoded peptide may be released locally to
influence PNS development. Previously defined Schwann
cell mitogens include PDGF, FGF, VEGF, and neuregu-
lins (Eccleston et al., 1990; Sondell et al., 1999; Taber-
nero et al., 1998; Verdi et al., 1996), which generally
employ tyrosine kinase cascades to enhance proliferation.
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but not desANP4-23, inhibited process outgrowth of dorsal
root sensory neurons. The fact that this effect was resistant
to the NPR-C specific analog desANP4-23, and that we
detected NPR-B transcripts in sensory ganglia, suggests that
this action is mediated by NPR-B. The finding that CNP
inhibited sensory neurite outgrowth suggests that the pep-
tide may serve as a repulsive guidance cue under some
circumstances, an activity it may share with other known
signaling molecules. It is notable that CNP gene transcripts
in the embryo were detected in areas which do not receive
major sensory neuron innervation, including the developing
vertebral bone and/or dura, the dorsal spinal cord VZ, and
the ventral motor horn. Moreover, while further character-
ization is necessary, this activity may be involved in
regulating growth of sensory axon terminals into blood
vessel walls (which might contain natriuretic peptides from
the blood or in endothelial cells). In this regard, cGMP,
which may be induced by natriuretic peptides either directly
via NPR-A or NPR-B (Anand-Srivastava and Trachte,
1994), or indirectly via NPR-C (Murthy et al., 2000), may
have a role in growth cone guidance (Song et al., 1998).
In contrast to the mitogenic action of natriuretic peptides
on Schwann cells, which appeared to be mediated primarily
by NPR-C, natriuretic peptides appeared to inhibit the
proliferation of cultured E10.5 mouse hindbrain neural
precursors via NPR-B. The evidence for this is that CNP
was more potent than desANP4-23, and that NPR-B and not
other receptor mRNA was detected in the E10.5 hindbrain.
Moreover, the finding that NPR-B gene transcripts were
detected in cells just outside the VZ suggests that this
receptor gene becomes expressed just as cells leave the cell
cycle. We speculate that CNP, produced in the actively
proliferating cells in the VZ, reinforces primary signals or
mechanisms that induce cells to leave the cell cycle.
We also found that CNP synergized with Shh to induce
the expression of the Shh target gene gli-1 in hindbrain
cultures. Robertson et al. (2001) recently reported that chick
natriuretic peptide promoted the ventralizing action of Shh
in chick dorsal spinal cord explants, an effect that could be
mimicked by cGMP analogs. Conversely, Shh signaling is
well known to be antagonized by cAMP and protein kinase
A in numerous developmental processes. Based on this and
results in mouse hindbrain cultures and chick explants, we
propose that cGMP and cAMP constitute opposing signals
that modulate Shh signaling. In this regard, another neuro-
peptide, pituitary adenylyl cyclase activating peptide
(PACAP) and its PAC1 receptor are expressed in the mouse
E10.5 hindbrain, and PACAP activation of cAMP inhibits
expression of gli-1 in these neural precursors (Waschek et
al., 1998).
The developmental action of natriuretic peptides appears
to be pleiotropic, reminiscent of that of several growth
factors, neurotrophins, and cytokines, as well as PACAP
(reviewed in Waschek, 2002). The pleiotropic activity of the
natriuretic factors is further indicated by their cell type-specific actions, stimulating and inhibiting DNA synthesis
in Schwann cells and embryonic hindbrain precursors,
respectively (shown herein), and inhibiting proliferation of
olfactory precursors (Simpson et al., 2002) and astrocytes
(Levin and Frank, 1991). Natriuretic peptides have also
been reported to stimulate DNA synthesis in embryonic
cardiomyocytes (Koide et al., 1996), and to inhibit the
proliferation of several other non-neural cell types, includ-
ing vascular smooth muscle cells (Cahill and Hassid, 1991),
kidney mesangial cells (Appel, 1990), chondrocytes (Hagi-
wara et al., 1996), and osteoblast-like cells (Hagiwara et al.,
1994).
Given that NPR-C is classically known for its role in
clearing excess natriuretic peptides, it was of interest that
this receptor appeared to mediate the mitogenic action of
natriuretic peptides in Schwann cells. This provides further
support for the idea that this receptor has a signaling
function (Anand-Srivastava and Trachte, 1994; Murthy et
al., 2000). Of additional interest was that the same NPR-C-
specific agonist that stimulated Schwann cell proliferation in
our studies was found to potently inhibit the proliferation of
astrocytes (Prins et al., 1996). Further study may reveal how
this receptor can mediate opposing proliferative actions on
these two glial phenotypes.
The detection of NPR-C and NPR-A in blood vessels in
the early embryonic brain may also be significant from a
developmental perspective. As discussed above, natriuretic
peptides regulate the proliferation of vascular smooth mus-
cle, and may be involved in other aspects of angiogenesis in
the brain, such as recruitment of vascular smooth muscle
cells (Ikeda et al., 1997; Kohno et al., 1997), and choroid
plexus formation. The peptides are also potentially involved
in establishment of blood–brain and blood–nerve barriers.
One puzzling result reported here is that we could not
detect gene expression for any of the known natriuretic
peptide receptors in the embryonic forebrain, nor did we
detect peptide effects in our well-characterized embryonic
cortical precursor culture model (unpublished results; Lu
and DiCicco-Bloom, 1997; Nicot and DiCicco-Bloom,
2001), though further study is warranted. Three other groups
focused specifically on rat brain and reported a highly
abundant presence of 125I-ANP binding sites in the telen-
cephalon, localized to the VZ (Brown and Zuo, 1995; Tong
and Pelletier, 1990; Zorad et al., 1993). These sites could be
detected as early as E13 (Tong and Pelletier, 1990),
corresponding approximately to E12 in mice. Radioligand
displacement studies indicated that these sites appeared to
be ‘‘NPR-C-like’’ receptors (Brown and Zuo, 1995; Zorad
et al., 1993). One potential explanation for the apparent
discrepancy would be that 125I-ANP binding sites in the
embryonic telencephalon correspond to a natriuretic recep-
tor that has not yet been cloned or characterized. Regardless,
our expression and functional studies now identify the
natriuretic peptide ligand/receptor systems as potential par-
ticipants in development of the peripheral and central
nervous systems.
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